Healthcare Global Enterprises Ltd
NSE:HCG
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
315.2
474.65
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Healthcare Global Enterprises Ltd
Healthcare Global Enterprises Ltd
Revenue
Healthcare Global Enterprises Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Healthcare Global Enterprises Ltd
NSE:HCG
|
Revenue
₹19.7B
|
CAGR 3-Years
20%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
Revenue
₹190.6B
|
CAGR 3-Years
22%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
F
|
Fortis Healthcare Ltd
NSE:FORTIS
|
Revenue
₹70.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
Revenue
₹54.1B
|
CAGR 3-Years
29%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Narayana Hrudayalaya Ltd
NSE:NH
|
Revenue
₹52.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
G
|
Global Health Ltd
NSE:MEDANTA
|
Revenue
₹32.8B
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Healthcare Global Enterprises Ltd
Glance View
HealthCare Global Enterprises Ltd. provides imaging and diagnostics services for cancer treatment. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2016-03-30. The firm is involved retail sale of pharmaceuticals, medical and orthopedic goods and toilet articles. The company operates cancer care network under the HCG brand. The company operates infertility treatment clinics providing assisted reproductive services under brand Milann. The firm operates eight Milann fertility centers, which provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation; and follow a multidisciplinary and technology-focused approach to diagnosis and treatment. Milann fertility centers also offer training programs for fertility specialists and embryologists. Under the Triesta brand, it provides clinical reference laboratory services with specialization in oncology.
See Also
What is Healthcare Global Enterprises Ltd's Revenue?
Revenue
19.7B
INR
Based on the financial report for Jun 30, 2024, Healthcare Global Enterprises Ltd's Revenue amounts to 19.7B INR.
What is Healthcare Global Enterprises Ltd's Revenue growth rate?
Revenue CAGR 5Y
14%
Over the last year, the Revenue growth was 13%. The average annual Revenue growth rates for Healthcare Global Enterprises Ltd have been 20% over the past three years , 14% over the past five years .
You don't have any saved screeners yet
